BioXcel Therapeutics Inc

NEW
HAM:BX20 (USA)  
€ 0.19 -0.44 (-69.97%) Aug 28
At Loss
Market Cap:
€ 4.88M ($ 5.66M)
Enterprise V:
€ 83.50M ($ 96.86M)
Volume:
40.00K
Avg Vol (2M):
40.00K
Trade In:

BioXcel Therapeutics Inc (HAM:BX20) Dividend

BioXcel Therapeutics Inc (HAM:BX20) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -133.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: HAM:BX20 Dividend

Does BioXcel Therapeutics Inc (HAM:BX20) pay a dividend?

BioXcel Therapeutics Inc (HAM:BX20) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't BioXcel Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. BioXcel Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -133.3% over the past 3 years.

What are dividend-paying alternatives to BioXcel Therapeutics Inc?

For dividend-paying alternatives in BioXcel Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.